THURSDAY, 22 JUNE 2017

HALL  A

08:30-10:30 SESSION: RF-MW-HIFU ABLATION

Chairs: N. KELEKIS, D. KARDAMAKIS

8:30-8:45 THE ROLE OF THE THERMAL ABLATION, P. FILIPPOUSIS

8:45-9:00 ABLATION BONE METASTASES, A. KELEKIS 

9:00-9:15 TECHNICAL ASPECTS OF MWA, M. CAVAGNARO

9:15-9:40 HIFU SYSTEMS: TECHNOLOGY AND CLINICAL PRACTICE, H. GRUELL 

9:40-10:10 DEBATE: RF-MW ABLATION OR STEREOTACTIC RT FOR LUNG AND LIVER METASTASES?,

P. FILLIPIADIS (pending) vs C. SONG

10:10-10:30 DISCUSSION : V. KOULOULIAS, N. KELEKIS, D. KARDAMAKIS

In parallel with

HALL  B

09:00-10:30 SESSION: CHEMOTHERAPY AND HYPERTHERMIA

Chairs: V. ARMONIS, P. PAPAGELOPOULOS, S. GIASSAS

9:00-9:15 CHEMOTHERAPY AND REGIONAL HYPERTHERMIA IN SOFT TISSUE SARCOMA - UPDATE OF A PHASE 3 STUDY, R. ISSELS

9:15-09:30 DISCUSSION

 

09:30-10:30 ORAL SESSION 2

Chairs: V. ARMONIAS, P. PAPAGELOPOULOS, S. GIASSAS

Topics: Chemotherapy & Hyperthermia / Hyperthermia for pelvic tumors & clinical practice / Treatment planning / Whole body hyperthermia

OP-06 - OP-10

10:30-11:00 COFFEE BREAK

                     HALL  A

11:00-12:30 SESSION NANOPARTICLES AND HYPERTHERMIA

11:00-11:15 WHICH ARE THE BEST NANOPARTICLES FOR HYPERTHERMIA?, M. ANGELAKERIS

11:15-11:30 NANOPARTICLE-MEDIATED DRUG DELIVERY TO TREAT CANCER, T. TEN HAGEN

11:30-11:45 TARGETED NANOPARTICLES FOR CANCER: IMMUNE MICROENVIRONMENT OF TUMOURS DETEREMINES UPTAKE AND RETENTION OF NANOPARTICLES , R. IVKOV

11:45-12:00 DESIGN AND APPLICATION OF TEMPERATURE SENSITIVE LIPOSOMES FOR HYPERTHERMIA INDUCED DRUG DELIVERY, H. GRUELL 

12:00-12:30 DISCUSSION

 

12:30 - 14:00 ORAL SESSION 3

Chairs: M. GAZOULI, T. SAMARAS

Topics: Nanoparticles & hyperthermia

OP011 - OP18

 

In parallel with

HALL  B

11:00 – 12:00 SPECIAL SESSION: UROLOGICAL AND PERFUSIONAL HYPERTHERMIA

Chairs: A.-TH. PAPASTAVROU, J. VROUVAS

11:00-11:15 NON THERMAL EFFECTS OF RADIOFREQUENCY RADIATION, G. LEV 

11:15-11:30 OUR INITIAL EXPERIENCE ON HYPERTHERMIC INTRAVESICULAR CHEMOTHERAPY (HIVEC), A. P. LABANARIS

11:30-11:45 CLOSED TECHNIQUE WITH C02 AGITATION, AN INNOVATIVE SOLUTION FOR HIPEC, P. VILLAREJO

11:45-12:00 DISCUSSION

 

14:00-15:00 LUNCH BREAK

HALL  A

15:00-16:00 SESSION: HYPERTHERMIA FOR PELVIC TUMORS AND CLINICAL PRACTICE  

Chairs: K.PISTEVOU-GOMPAKI, P. PANTELAKOS

15:00-15:15 CERVICAL CANCER: WHAT WE HAVE LEARNED FROM CLINICAL TRIALS (PHASE III STUDY)?, C. MINNAAR

15:15-15:30 HYPERTHERMIA & CURRENT ONCOLOGICAL GUIDELINES: INDICATIONS & TECHNICAL CAPABILITIES FOR SELECTED TUMOR ENTITIES, P. WUST

15:30-15:45 PHASE II STUDY: HYPERTHERMIA AS A USEFUL TOOL FOR BOWEL PROTECTION IN RADIATION THERAPY, S. H. YOU

15:45-16:00  DISCUSSION

 

In parallel with

HALL B

15:00-17:00 ORAL SESSION 4

Chairs: H.D. TREFNA, G. MATSOPOULOS

Technology/Dosimetry

OP-19 - OP-28

POSTER AREA

15:30-17:00 POSTER PRESENTATIONS 2

Chairs: C. ANTYPAS, K. PLATONI, A. ARDAVANIS

Loco-regional Hyperthermia/ Superficial HT

PP-10 - PP-25

17:00-17:30 COFFEE BREAK 

HALL  A

17:30-18:30 INDUSTRY SPONSORED SYMPOSIUM    


18:30-19:30 PRESIDENTIAL SYMPOSIUM: THE PRESENT AND THE FUTURE OF HYPERTHERMIA: IS HYPERTHERMIA THE FOURTH PILLAR?

Chairs: V. KOULOULIAS, T. SAMARAS

18:30-18:50 LECTURE: NEED FOR MULTICENTER EUROPEAN TRIALS FOR COMBINED HYPERTHERMIA-RADIOTHERAPY: FOCUS, PRIORITIES, S. BODIS

18:50-19:30 Q&A

Participants: G. VAN RHOON (technology), S. BODIS (radio-hyperthermia), L. LINDNER (chemo-hyperthermia), T. TEN HAGEN (nanoParticles), H. GRUELL (HIFU),  A. SZASZ (immunomodulation), A. HERZOG (WBH) 

 

20:30 GALA DINNER (not included in registration fee - for more info visit the Social Events Section)

 

    

Important Dates

Congress Dates: June 21st - 23rd 2017 

Deadline for abstract submission: April 24th 2017 

Deadline for early registration fee: April 24th 2017 

Notification of acceptance / rejection: May 15th 2017 

Organized by

AFEA S.A. TRAVEL AND CONGRESS SERVICES

+30 210 36 68 842 - 854
+30 210 36 43 511
info@esho2017.eu

Follow us on